Kellanova vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
Kellanova acquired by Mars Inc. Aug 2024 for $35.9B ($83.50/share); Pringles, Cheez-It, Pop-Tarts, Eggo integrated into Mars global snacking alongside M&M's/Snickers competing with Frito-Lay and Mondelez.
About
Kellanova (formerly Kellogg Company's global snacking division) was a Chicago, Illinois-based snacking company — creator of Pringles (the world's second-largest potato chip brand), Pop-Tarts, Cheez-It, Rice Krispies Treats, MorningStar Farms plant-based foods, Eggo waffles, and Nutri-Grain cereal bars — that was created in August 2023 when Kellogg Company split into two independent public companies: Kellanova (global snacking brands, cereal outside North America) and WK Kellogg Co. (North American cereal brands). Kellanova was itself acquired by Mars, Incorporated in August 2024 in a $35.9 billion cash transaction ($83.50 per share) — one of the largest food industry acquisitions in history — ending Kellanova's brief 12-month existence as a standalone public company. Mars acquired Kellanova to expand its snacking portfolio (Mars's existing snacking brands include M&M's, Snickers, Twix, Kind bars, and Nature's Bakery) with Kellanova's salty snacks platform (Pringles, Cheez-It) and convenient breakfast products (Pop-Tarts, Eggo) — creating a combined snacking company with $35+ billion in revenue that competes directly with PepsiCo's Frito-Lay and Mondelez International's snacking portfolio. Prior to the Mars acquisition, Kellanova CEO Steve Cahillane had executed the strategic rationale for the split from WK Kellogg: snacking brands (impulse purchase, premium innovation, global growth) warranted a different capital allocation and growth investment profile than mature North American cereal brands (stable cash flow, distribution efficiency). Kellanova's FY2023 revenues totaled approximately $13 billion, with Pringles generating the highest brand-level profitability through its unique pressurized-air canister distribution system.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.